asa glp-1 agonist guidelines Perioperative management of patients on receptor agonists: Risks, recommendations, and future directions—A narrative review How should GLP-1 receptor agonists
Description
PubMed, Gupta, Dharmendra Kumar, and Arunima Chaudhuri

Further research is needed to explore the full therapeutic potential and long-term safety of GLP-1RAs across a broader range of metabolic and neurodegenerative disorders

doi: 10.1097/RHU.0000000000001949

Given the established cardiovascular and kidney benefits of SGLT2is for T2DM patients with CVDs, those at high risk, and those with CKD, along with recent cohort studies demonstrating their ability to enhance survival, reduce cardiovascular events, and preserve graft function in kidney KTRs with DM, we conducted additional analyses incorporating SGLT2is [38,39,40,41,42]
Am J Physiol Renal Physiol (2009) 297(6):F164755

[The Story of the Gila Monster]
